{"line_no":1,"decision":"manual_review_refine","rationale":"Removed DECOMPOSE/SOLVE scaffolding while preserving UMN-LMN/ALS/GBS core content and tables.","input_sha256":"9dc13cedda5dfd7bdee518e0c70b06731f77749c185e6aa486a3a2d844b2e12e","output_sha256":"5c79f13be81ffca12ee3ff92e001ac7b449ac9c5c70f0b23261b3d8483fb1728"}
{"line_no":2,"decision":"manual_review_refine","rationale":"Manual line-by-line review; diabetic trap, ALS, GBS framework preserved.","input_sha256":"1b3386b842dbd2f0739c499b978193781c35023b46225a3da9627173bf91e68e","output_sha256":"3b91d6a996be432fabd14e620d654e067c3b9606fdfee41d063a43e4d102245c"}
{"line_no":3,"decision":"manual_review_refine","rationale":"Manual line-by-line review; GBS diagnostics, differential table, facial palsy distinctions retained.","input_sha256":"66c73f2c25471c22cf7d8e67b1e9c2242ed05f701b44e6c4aaddcbab554afa88","output_sha256":"e64df4bf1e0f418813d3061e02ecf5efe423a432af379b6704f4253fb30fbba6"}
{"line_no":4,"decision":"manual_review_refine","rationale":"Removed synthesize/quiz CTA block; preserved rapid association bullets and next-topic clinical overview.","input_sha256":"1e5c97f051215f22ed8d14b1d416af3f642057a3a344314f4ab4b5b7586b72ca","output_sha256":"bdc8fa979ed7da8827cff108476cbe0a5eb8151daa84ac56ecead49df2253a3d"}
{"line_no":5,"decision":"manual_review_refine","rationale":"Manual line-by-line review; CNS infection structure and PML pathway retained.","input_sha256":"1acdd3c6519b4cd66a4de9a4a25e0f6d06d391f5a6ae88c83495c40ced31f77e","output_sha256":"bc7d2ca54744d4d9c0e217fb9c9de6c100382af0e2e4eee3284f8322384ac403"}
{"line_no":6,"decision":"manual_review_refine","rationale":"Manual line-by-line review; meningitis/abscess/SEA decision rules and contraindications retained.","input_sha256":"f61221848a03931190f92e8a9fc221ed5a3903744bd75f6ccfc1f713ee8b2ff2","output_sha256":"42237462e174c1dd5291ca832b7cc81915845edef792decbfe1bbac14ee71c8b"}
{"line_no":7,"decision":"manual_review_refine","rationale":"Manual line-by-line review; CNS infection recap and tumor overview table preserved.","input_sha256":"0b519a89a984240308b62b374af36d61b850d62459c6becc3eda6b778320ea08","output_sha256":"135e2073455cf626bdff09ff32de9578a3cf319d59815a741091aba494f3fb39"}
{"line_no":8,"decision":"manual_review_refine","rationale":"Manual line-by-line review; tumor classification and benign-vs-metastatic doorway logic retained.","input_sha256":"ad71af07df8b4d9f4def8b52c45dcfc4c4fd9bc5e25acc0e87331daa8901740b","output_sha256":"29d9118fa4a548784b8d2e3502c08b34da8dbe218287122386cd4b42a597692e"}
{"line_no":9,"decision":"manual_review_refine","rationale":"Manual line-by-line review; sellar/pineal/red-flag symptom differentiation retained.","input_sha256":"88f8d4e11323e6d3caaab5cf33245d53e0060377667a5a2d2fc74a63ac7c2626","output_sha256":"80185c1f2a4a667aa5883f6da89d1fdd6e250d77e4cee03bd79d824ec4134377"}
{"line_no":10,"decision":"manual_review_refine","rationale":"Manual line-by-line review; metastatic-primary tumor management algorithms retained.","input_sha256":"274f8cac9d16bd2cbebd636c6d29c7ab643f6c8d5b14a6afdb97ae80e0d733d5","output_sha256":"7fd9fe32244a217cecfa594f7d5d248a364050b32912bb693228407d77a4373e"}
{"line_no":11,"decision":"manual_review_refine","rationale":"Removed caveat/quiz prompt/chatty greeting; preserved key pearls and pediatric-neuro transition context.","input_sha256":"6727fd7ca4be4048fb8486781bb5568fce12f1f4f129bf1547cca35c7dc0d95a","output_sha256":"c8cde4f50f00dda073b596b83d822eaa4e1aae015425c52af42e0870fbb83039"}
